K M Izumi
Overview
Explore the profile of K M Izumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izumi K
Prog Mol Subcell Biol
. 2004 Jun;
36:269-88.
PMID: 15171616
Latent EBV growth transformation of resting B-cells into indefinitely proliferating cell lines is a successful viral strategy for survival in its host and the basis of several human malignancies. EBV...
2.
Izumi K
Semin Cancer Biol
. 2001 Oct;
11(6):407-14.
PMID: 11669602
Epstein-Barr virus (EBV) is able to infect primary B-lymphocytes but usually does not proceed to replicate more virions. Instead, EBV persists as an incomplete virus and expresses 12 gene products...
3.
4.
Higuchi M, Izumi K, Kieff E
Proc Natl Acad Sci U S A
. 2001 Apr;
98(8):4675-80.
PMID: 11296297
Epstein-Barr virus encodes integral membrane proteins LMP1 and LMP2A in transformed lymphoblastoid cell lines. We now find that LMP1 associates with the cell cytoskeleton through a tumor necrosis factor receptor-associated...
5.
Cahir McFarland E, Izumi K, Mosialos G
Oncogene
. 1999 Dec;
18(49):6959-64.
PMID: 10602470
Epstein-Barr virus (EBV) transforms resting primary human B lymphocytes into indefinitely proliferating lymphoblastoid cell lines in vitro and is associated with several human malignancies in vivo. Recombinant EBV genetic analyses...
6.
Kaye K, Izumi K, Li H, Johannsen E, Davidson D, Longnecker R, et al.
J Virol
. 1999 Nov;
73(12):10525-30.
PMID: 10559372
An Epstein-Barr virus (EBV) recombinant (MS231) that expresses the first 231 amino acids (aa) of LMP1 and is truncated 155 aa before the carboxyl terminus transformed resting B lymphocytes into...
7.
Izumi K, Cahir McFarland E, Riley E, Rizzo D, Chen Y, Kieff E
J Virol
. 1999 Nov;
73(12):9908-16.
PMID: 10559303
Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) is essential for EBV-mediated transformation of primary B lymphocytes. LMP1 spontaneously aggregates in the plasma membrane and enables two transformation effector sites...
8.
Izumi K, Cahir McFarland E, Ting A, Riley E, Seed B, Kieff E
Mol Cell Biol
. 1999 Jul;
19(8):5759-67.
PMID: 10409763
A site in the Epstein-Barr virus (EBV) transforming protein LMP1 that constitutively associates with the tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein TRADD to mediate NF-kappaB and c-Jun...
9.
Devergne O, Cahir McFarland E, Mosialos G, Izumi K, Ware C, Kieff E
J Virol
. 1998 Sep;
72(10):7900-8.
PMID: 9733827
In this study, we investigated the induction of cellular gene expression by the Epstein-Barr Virus (EBV) latent membrane protein 1 (LMP1). Previously, LMP1 was shown to induce the expression of...
10.
Izumi K, Kieff E
Proc Natl Acad Sci U S A
. 1997 Nov;
94(23):12592-7.
PMID: 9356494
The Epstein-Barr virus latent membrane protein 1 (LMP1) is essential for the transformation of B lymphocytes into lymphoblastoid cell lines. Previous data are consistent with a model that LMP1 is...